Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

NCT06819735 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: DT-7012
DRUG: Immune checkpoint inhibitor

Sponsor

Domain Therapeutics Australia Pty Ltd

Collaborators

[object Object]